featured
Rivaroxaban Associated With Increased Bleeding Risks vs Dabigatran in Elderly Patients With Nonvalvular Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Internal Medicine